Teacher Retirement System Of Texas Atara Biotherapeutics, Inc. Transaction History

Teacher Retirement System Of Texas

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$2.8 - $5.46 $1,181 - $2,304	422 Added 1.73%	24,844 $72,000
Q4 2022 Feb 10, 2023	SELL	$2.85 - $5.18 $4,049 - $7,360	-1,421 Reduced 5.5%	24,422 $80,000
Q3 2022 Nov 03, 2022	BUY	$2.85 - $8.73 $39,181 - $120,020	13,748 Added 113.67%	25,843 $98,000
Q2 2022 Aug 09, 2022	SELL	$4.69 - $9.84 $15,720 - $32,983	-3,352 Reduced 21.7%	12,095 $94,000
Q1 2022 May 09, 2022	BUY	$8.44 - $16.89 $14,584 - $29,185	1,728 Added 12.6%	15,447 $144,000

Q4 2021 Feb 10, 2022	BUY	$14.7 - $19.89 $33,339 - $45,110	2,268 Added 19.81%	13,719 $216,000
Q3 2021 Nov 09, 2021	BUY	$11.99 - $17.9 $137,297 - $204,972	11,451 New	11,451 $205,000
Q3 2018 Nov 09, 2018	SELL	$35.05 - $43.5 $214,155 - $265,785	-6,110 Closed	0 $0
Q2 2018 Aug 06, 2018	SELL	$35.15 - $51.45 $19,613 - $28,709	-558 Reduced 8.37%	6,110 $225,000
Q1 2018 May 08, 2018	BUY	$18.0 - $48.35 $120,024 - $322,397	6,668 New	6,668 $260,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.